L2P RESEARCH
Dead / Abandoned — Abandoned — no statement of use filed (as of 08 Feb 2021)
What this means for you
This application is over — abandoned 08 Feb 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88746144
- Mark type
- Stylized text
- Filed
- 03 Jan 2020
- Published for opposition
- 12 May 2020
- Abandoned
- 08 Feb 2021
Goods and services
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields; Research and development of advanced learning technologies and teaching methods; Research and development of new products; Research and development of new products for others; Research and development of vaccines and medicines; Research and development services in connection with physics; Research and development services in the field of antibodies; Research in the area of semiconductor processing technology; Research in the field of chemistry; Research on the subject of pharmaceuticals; Agrochemical research services; Bacteriological research; Bacteriological consultation and research; Biochemical research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical research; Conducting clinical trials for others; Consulting services in the field of hydrological research; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Genetic testing for scientific research purposes; Genetic testing of laboratory animals for research purposes; Genotyping services for research or analysis purposes; Industrial research in the field of Biotechnology; Industrial research in the field of Immunology; Integrated scientific research on vermin for greenhouses and harvest crops; Laboratory research services relating to pharmaceuticals; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of Oncology; Medical and scientific research in the field of Cancer; Medical and scientific research in the field of Nature Therapeutics; Pharmaceutical research and development; Pharmaceutical research services; Product research; Product research and development; Providing information in the field of plant genetics research resources; Providing medical research and scientific research information in the field of oncology via the Internet; Providing scientific research information in the field of Tumor Immunology; Providing scientific research information in the field of Pre clinical Research; Providing scientific research information in the field of Animal Research; Scientific research; Scientific research and development; Scientific research consulting in the field of cosmetics; Scientific research consulting in the field of in vitro fertilization; Scientific research for medical purposes in the area of cancerous diseases; Scientific and technological research relating to patent mapping; Technical research in the field of pharmaceutical studies; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Zoological research and consultation
Owner
- Lab TO Pharmacy, LLC, Annville, PA, US
- Lab TO Pharmacy, LLC, Annville, PA, US
Prosecution history
- 08 Feb 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 08 Feb 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 07 Jul 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 May 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 May 2020 — PUBLISHED FOR OPPOSITION
- 22 Apr 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Apr 2020 — ASSIGNED TO LIE
- 24 Mar 2020 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Mar 2020 — EXAMINER'S AMENDMENT ENTERED
- 24 Mar 2020 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 24 Mar 2020 — EXAMINERS AMENDMENT E-MAILED
- 24 Mar 2020 — EXAMINERS AMENDMENT -WRITTEN
- 24 Mar 2020 — ASSIGNED TO EXAMINER
- 08 Jan 2020 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 07 Jan 2020 — NEW APPLICATION ENTERED